Effective oral hypomethylating drugs in intermediate-risk or high-risk myelodysplasia: a breakthrough?

Find Full text
Publication year
2019
Author(s)
Witte, T.J. de
Source
Lancet Haematology, 6, 4, (2019), pp. e170-e171
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/202794   https://hdl.handle.net/2066/202794
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.